STOCK TITAN

Planned 10,321-share Verastem (NASDAQ: VSTM) sale disclosed in filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Verastem, Inc. insider Daniel Paterson has filed a Form 144 to sell 10,321 shares of Verastem common stock. The planned sale has an aggregate market value of $73,851.00 based on the figures provided, with the shares to be sold through Shareworks by Morgan Stanley on the NASDAQ, with an approximate sale date of 01/12/2026. Verastem had 66,776,006 common shares outstanding according to the notice.

The 10,321 shares proposed for sale were acquired on 01/10/2025 through the vesting of a restricted stock unit award from Verastem, with the same date listed as the payment date and the consideration described as N/A. The filing also lists multiple prior sales of Verastem securities by Daniel Paterson over the past three months, including 3,299 shares sold on 11/03/2025 for $32,146.00 and 2,000 shares sold on 12/11/2025 for $20,000.00.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Verastem (VSTM)'s latest Form 144 filing disclose?

The Form 144 discloses that Daniel Paterson plans to sell 10,321 shares of Verastem, Inc. common stock, with an aggregate market value of $73,851.00, on the NASDAQ through Shareworks by Morgan Stanley.

How many Verastem (VSTM) shares are being registered for potential sale in this Form 144?

The notice covers a proposed sale of 10,321 shares of Verastem common stock, with an aggregate market value listed as $73,851.00 in the filing.

How were the Verastem (VSTM) shares in this Form 144 acquired?

The 10,321 shares were acquired on 01/10/2025 through the vesting of a restricted stock unit award from Verastem, Inc., with the nature of payment described as N/A.

What does the Form 144 say about Verastem (VSTM) shares outstanding?

The filing states that there were 66,776,006 shares of Verastem common stock outstanding, providing context for the size of the proposed 10,321-share sale.

Which broker and exchange are involved in the planned Verastem (VSTM) share sale?

The Form 144 lists Shareworks by Morgan Stanley as the broker for the proposed sale, with trading to occur on the NASDAQ stock exchange.

What prior Verastem (VSTM) stock sales by Daniel Paterson are disclosed?

The filing lists several past three-month sales by Daniel Paterson, including 3,299 Verastem securities sold on 11/03/2025 for $32,146.00 and 2,000 sold on 12/11/2025 for $20,000.00, among other transactions.

Verastem

NASDAQ:VSTM

VSTM Rankings

VSTM Latest News

VSTM Latest SEC Filings

VSTM Stock Data

497.11M
70.84M
0.82%
89.08%
25.94%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEEDHAM